Literature DB >> 2063416

Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents.

E M Eugui1, A Mirkovich, A C Allison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2063416

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil.

Authors:  Douglas E Gladstone; Marc G Golightly; Kenneth W Zamkoff
Journal:  Rheumatol Int       Date:  2005-02-10       Impact factor: 2.631

2.  Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.

Authors:  Tim Ulinski; Laurence Dubourg; Marie Hélène Saïd; Bernadette Parchoux; Bruno Ranchin; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2005-02-18       Impact factor: 3.714

Review 3.  The changing face of liver transplantation.

Authors:  C Shorrock; J Neuberger
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

4.  Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells.

Authors:  M Colic; Z Stojic-Vukanic; B Pavlovic; D Jandric; I Stefanoska
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

5.  Prediction of Free from Total Mycophenolic Acid Concentrations in Stable Renal Transplant Patients: A Population-Based Approach.

Authors:  Helena Colom; Franc Andreu; Teun van Gelder; Dennis A Hesselink; Brenda C M de Winter; Oriol Bestard; Joan Torras; Josep M Cruzado; Josep M Grinyó; Núria Lloberas
Journal:  Clin Pharmacokinet       Date:  2018-07       Impact factor: 6.447

6.  Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes.

Authors:  C Alfieri; A C Allison; E Kieff
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

7.  Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.

Authors:  T Furlong; P Martin; M E D Flowers; F Carnevale-Schianca; R Yatscoff; T Chauncey; F R Appelbaum; H J Deeg; K Doney; R Witherspoon; B Storer; K M Sullivan; R Storb; R A Nash
Journal:  Bone Marrow Transplant       Date:  2009-04-20       Impact factor: 5.483
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.